Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Sat, Jul 12th, 2025

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

Teva Pharmaceutical (TEVA) Just Flashed a Statistically Viable Signal for Bullish Traders

Using principles from applied game theory, options traders may have an intriguing opportunity with TEVA stock.

Merck spends $10 billion for Verona, gaining access to its COPD medication

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal

$SPX : 6,259.75 (-0.33%)
MRK : 83.36 (-0.79%)
$DOWI : 44,371.51 (-0.63%)
$IUXX : 22,780.60 (-0.21%)
'Lord of the Rings' director backs long shot de-extinction plan, starring New Zealand's lost moa

Filmmaker Peter Jackson's fascination with a large extinct New Zealand bird has led to an unusual partnership with a biotech company known for its grand and controversial plans to bring back lost species...

The Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.

This clinical-stage biotech stock has a strong pipeline capable of creating the next Moderna.

$SPX : 6,259.75 (-0.33%)
MRNA : 33.64 (-1.87%)
REGN : 567.74 (+1.43%)
NTLA : 11.53 (-5.14%)
Why This Wildcard Stock Could Be a Future Star

Recursion’s slow and steady start could lead to a bright future in biotech.

NVDA : 164.92 (+0.50%)
RXRX : 5.28 (-7.61%)
RHHBY : 40.4900 (-1.77%)
SNY : 48.61 (-1.48%)
Up 515%, Watch This Biopharma Breakout

Verona Pharma (VRNA) is showing exceptional technical strength, hitting a new high in morning trading on June 24. The stock has a 100% technical “Buy” signal via Barchart. The stock has surged 515%...

VRNA : 104.83 (-0.02%)
RSG : 241.21 (+0.47%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar